-
-
-
-
-
-
-
TCR² Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
TCR2 Therapeutics (TCRR) Announces $125M Proposed Public Offering of Common Stock
-
-
-
-
-
-
-
TCR2 Therapeutics (TCRR) Prices 8M Share Common Offering at $15.50/Sh
-
-
-
-
-
-
-
TCR² Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
TCR2 Therapeutics Announces Exercise of Over-Allotment Option
-
-
-
-
-
69,742 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

